MENGOLI, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 3023
EU - Europa 471
AS - Asia 217
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3714
Nazione #
US - Stati Uniti d'America 3021
IT - Italia 223
CN - Cina 150
DE - Germania 72
FI - Finlandia 53
SE - Svezia 51
VN - Vietnam 50
UA - Ucraina 29
GB - Regno Unito 15
IN - India 8
RU - Federazione Russa 8
IE - Irlanda 5
FR - Francia 4
AL - Albania 3
KH - Cambogia 3
CA - Canada 2
ES - Italia 2
NL - Olanda 2
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
PH - Filippine 1
SG - Singapore 1
Totale 3714
Città #
Fairfield 512
Chandler 316
Houston 314
Woodbridge 306
Ann Arbor 293
Cambridge 187
Ashburn 178
Wilmington 177
Seattle 158
Jacksonville 144
Princeton 62
Beijing 53
Dong Ket 50
Des Moines 41
San Diego 41
Boardman 29
Nanjing 26
Padova 23
Medford 21
Helsinki 20
Roxbury 16
Falls Church 14
Milan 11
Nanchang 9
Guangzhou 8
Aprilia 7
Redwood City 7
Hefei 6
Jiaxing 6
Norwalk 6
Santa Cruz 6
Changsha 5
Dublin 5
Palermo 5
Senigallia 5
Shenyang 5
Tianjin 5
Jinan 4
Medicina 4
Rome 4
Chicago 3
Hebei 3
Lanzhou 3
London 3
Ningbo 3
Trieste 3
Altissimo 2
Buffalo 2
Chieti 2
Dallas 2
Fuzhou 2
Haikou 2
Indiana 2
Jesi 2
Napoli 2
New York 2
Torino 2
Vicenza 2
Zhengzhou 2
Aachen 1
Ahmedabad 1
Algiers 1
Amsterdam 1
Anzio 1
Appignano 1
Ardabil 1
Argenteuil 1
Atri 1
Augusta 1
Baghdad 1
Baotou 1
Barcelona 1
Bari 1
Borås 1
Bovezzo 1
Brescia 1
Camponogara 1
Carpi 1
Casalbordino 1
Castellarano 1
Cento 1
Chongqing 1
Cincinnati 1
Como 1
Crotone 1
Everett 1
Felino 1
Ferentino 1
Florence 1
Fossano 1
Genova 1
Hangzhou 1
Iligan City 1
Kharkiv 1
Kunming 1
Los Angeles 1
Milazzo 1
Modena 1
Mountain View 1
Nürnberg 1
Totale 3174
Nome #
Cistite incrostata alcalina da Corynebacterium Urealyticum: un caso clinico. 281
Clostridium difficile TxA(C314) and SLP-36kDa enhance the immune response toward a co-administered antigen 145
Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: Complexity and vaccine implications 134
Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men 133
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment 124
Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection 124
A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation 123
Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection 122
A Prospective Study on Modulation of Immunosuppression for Epstein-Barr Virus Reactivation in Pediatric Patients Who Underwent Unrelated Hematopoietic Stem-Cell Transplantation. 118
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy 113
Cytomegalovirus (CMV) enzyme-linked immunosorbent spot assay but not cmv quantiferon assay is a novel biomarker to determine risk of congenital cmv infection in pregnant women 112
Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated with Increased Risk of Fetal Infection in Primarily Infected Pregnant Women 110
Testing for cytomegalovirus in pregnancy 104
Case report: Kinetics of Epstein-Barr virus load in a bone marrow transplant patient with no sign of lymphoproliferative disease 98
HPV genotype prevalence in cervical specimens with abnormal cytology: A report from north-east Italy 95
Relationship between virulence factor genes in bovine Staphylococcus aureus subclinical mastitis isolates and binding to anti-adhesin antibodies 93
null 92
Mucosal genetic immunization against four adhesins protects against Staphylococcus aureus-induced mastitis in mice. 91
Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients. 91
Evaluation of a near patient test and ELISA-based assays for detecting anti-herpes simplex virus type-2 antibodies 89
The real-time polymerase chain reaction-guided modulation of immunosuppression enables the pre-emptive management of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation. 89
Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection. 88
Vaginal dysplastic lesions in women with hysterectomy and receiving radiotherapy are linked to high-risk human papillomavirus 87
Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients. 84
Encrusted cystitis by Corynebacterium urealyticum: a case report with novel insights into bladder lesions. 82
Immune reconstitution complicated by CMV retinitis in a pediatric patient who underwent haploidentical CD34+-selected hematopoietic stem cell transplant for acute lymphoblastic leukemia 79
HPV genotype prevalence in cervical specimens with abnormal cytology: A report from north-east Italy 76
CMV SPECIFIC IMMUNE RECONSTITUTION IN HTx PATIENTS TREATED WITH PRE-EMPTIVE STRATEGY: LIGHTS AND SHADOWS 74
Evaluation of a near-patient test and 2 enzyme-linked immunosorbent assay-based assays for detecting anti-herpes simplex virus type-2 antbodies 71
Interaction of HSV-1 and HIV-1 in human CD4 lymphocytes: Role of acyclovir. 38th Interscience 69
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment 61
Human cytomegalovirus DNAemia and preemptive treatment of CMV infection in children after hematopoietic stem-cell transplantation: Is any question settled? 59
Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation 59
Distribution of human papillomavirus types in the anogenital tract of females and males. 59
Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach 57
The value of near patient test in the diagnosis of HSV infection. 54
A prospective evaluation of sensitivity and specificity of BK viruria and BK viraemia in paediatric patients given allogeneic haematopoietic stem cell transplantation with haemorrhagic cystitis 52
EVALUATION OF CMV SPECIFIC T-CELL RESPONSE IN HEART TRANSPLANT RECIPIENTS 43
Successful treatment of CMV retinitis after haploidentical CD34+-selected haematopoietic stem cell transplant (HSCT) for T-cell acute lymphoblastic leukaemia (T-ALL) 42
Assessment of efficacy and renal toxicity of pre-emptive therapy for CMV reactivation in paediatric patients who underwent allogeneic stem cell transplantation 30
No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 months follow-up study 25
Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: A 24-month longitudinal study 24
Four-Year Follow-Up of the Maternal Immunological, Virological and Clinical Settings of a 36-Year-Old Woman Experiencing Primary Cytomegalovirus Infection Leading to Intrauterine Infection 3
Totale 3759
Categoria #
all - tutte 6281
article - articoli 5749
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12030


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201858 0000 00 00 932917
2018/2019398 703512 57 919 666131101
2019/2020867 101272283 8865 78104 113787236
2020/2021684 47532656 4548 3266 103319384
2021/2022590 15736736 3726 3163 37876121
2022/2023557 96782580 8791 349 48000
Totale 3759